Background-Oxidative stress seems to be present in all forms of hypertension. Thus, we tested the hypothesis that high intraluminal pressure (P i ) itself, by activating vascular oxidases, elicits increased superoxide (O 2 ·Ϫ ) production interfering with flow-induced dilation. Methods and Results-Isolated, cannulated rat femoral arterial branches were exposed in vitro (for 30 minutes) to normal P i (80 mm Hg) or high P i (160 mm Hg). High P i significantly increased vascular O 2 ·Ϫ production (as measured by lucigenin chemiluminescence and ethidium bromide fluorescence) and impaired endothelium-dependent dilations to flow; these effects could be reversed by superoxide dismutase. Administration of the NAD(P)H oxidase inhibitor diphenyleneiodonium, apocynin, the protein kinase C (PKC) inhibitor chelerythrine or staurosporin or the removal of extracellular Ca 2ϩ during high P i treatment prevented the increases in O 2 ·Ϫ production, whereas administration of losartan or captopril had no effect. High P i resulted in significant increases in intracellular Ca 2ϩ ([Ca 2ϩ ] i ) in the vascular wall (fura 2 fluorescence) and phosphorylation of PKC␣ (Western blotting). The PKC activator phorbol myristate acetate significantly increased vascular O 2 ·Ϫ production, which was inhibited by superoxide dismutase, diphenyleneiodonium, chelerythrine, or removal of extracellular Ca 2ϩ . Both high P i and phorbol myristate acetate increased the phosphorylation of the NAD(P)H oxidase subunit p47
N umerous studies in humans 1 and animals [2] [3] [4] [5] [6] suggest that increased superoxide (O 2 ·Ϫ ) production contributes significantly to the functional alterations of arteries present in hypertension. In peripheral arteries and arterioles, increased levels of O 2 ·Ϫ have been shown to decrease the bioavailability of the endothelium-derived vasodilator nitric oxide to flow, 6, 7 thereby contributing to the maintenance of elevated peripheral resistance. However, the stimuli and mechanisms underlying increased O 2 ·Ϫ production in hypertension are not completely understood.
The vascular effects of hypertension are complex and are likely to be induced, at least in part, by increased levels of neurohumoral factors. Among the humoral factors, angiotensin has been suggested to increase O 2 ·Ϫ generation in vascular cells. 3, 4, 8, 9 However, oxidative stress seems to be present in virtually all forms of hypertension, 4, 5 including low-renin hypertension, 10 despite the differences in plasma levels of circulating factors. Importantly, in angiotensin-infused rats, reduction of blood pressure with hydralazine or spironolactone (which is unlikely to affect angiotensin levels) normalized aortic O 2 ·Ϫ production. 8, 11 Reduction of blood pressure in rats infused with both angiotensin and norepinephrine by hydralazine also normalized increased plasma levels of 8-epiprostaglandin F 2␣ , a marker of oxidative stress in vivo. 12 Thus, it is logical to hypothesize that high intraluminal pressure (P i ) itself can also promote vascular O 2 ·Ϫ generation in hypertension. This idea is congruent with previous observations that even short-term increases in P i , both in vivo and in vitro, impair endothelial function, [13] [14] [15] [16] an effect that can be prevented by superoxide dismutase (SOD). 17 However, the possible role of high P i alone in the upregulation of arterial O 2 ·Ϫ production and the underlying signaling mechanisms has not yet been elucidated.
To test the hypothesis that the presence of high P i per se, by activating vascular oxidases, elicits oxidative stress, we investigated pressure-induced O 2 ·Ϫ production in isolated arteries in vitro, a condition in which neurohumoral factors are absent. Also, we aimed to elucidate the contribution of possible vascular sources of O 2 ·Ϫ , including NAD(P)H oxi-dases, 4, 5 and the role of mechanosensitive pathways, such as Ca 2ϩ and protein kinase C (PKC)-dependent signaling mechanisms. 2, 3, 18 
Methods

Vessel Isolation and Functional Studies
Functional studies were conducted on pressurized branches of the femoral artery (diameter, Ϸ200 m) that were isolated from male Wistar rats (nϭ20; 14 weeks old; Charles River Laboratories, Wilmington, Mass), as previously described. 17, 19, 20 At normal P i (80 mm Hg), flow-induced dilations were obtained; then, P i was increased to 160 mm Hg for 30 minutes. In other experiments, vessels were exposed to high P i in the presence of SOD (200 U/mL), apocynin (3ϫ10 Ϫ4 mol/L, a NAD(P)H oxidase inhibitor 5, 21 ), losartan (10 Ϫ6 mol/L, an angiotensin II type 1 receptor inhibitor), or captopril (10 Ϫ6 mol/L, an angiotensin-converting enzyme inhibitor). After the high P i exposure, P i was returned to 80 mm Hg, and flow-induced responses were reassessed. In separate experiments, arteries were incubated with Ca 2ϩ -free solution during high P i treatment, then flow-induced responses were reassessed after readministering Ca 2ϩ (at 80 mm Hg).
Measurement of Vascular O 2 ·؊ Levels
Proximal arterial segments were isolated and cannulated, and the production of O 2 ·Ϫ in response to step increases in P i (from 0 mm Hg to 80 mm Hg or from 0 mm Hg to 160 mm Hg) was continuously measured by the real-time lucigenin (10 mol/L) chemiluminescence method using a vessel-perfusion system coupled to a photomultiplier-based detector. 21 Pressure-induced changes in lucigenin chemiluminescence were also measured in the presence of diphenyleneiodonium (DPI; 10 Ϫ5 mol/L, an inhibitor of flavoproteincontaining oxidases, including NAD(P)H oxidases) or chelerythrine (10 Ϫ6 mol/L, an inhibitor of PKC and PKC-induced NAD(P)H activity 3 
Ethidium Bromide Fluorescence
Hydroethidine was used to localize pressure-induced O 2 ·Ϫ production, as described previously. 22 Identical branches of the left and right femoral arteries were cannulated, pressurized (to 80 or 160 mm Hg), and exposed to hydroethidine (2ϫ10 Ϫ6 mol/L, at 37°C, for 15 minutes). They were then embedded, snap-frozen in liquid nitrogen, and cryosectioned. The sections were immunostained for smooth muscle ␣-actin. We used 4,6-diamidino-2-phenylindole dihydrochloride (DAPI) for nuclear staining, and fluorescent images were collected. Normal and high P i -exposed vessels were processed and imaged in parallel.
Measurement of Endothelial and Smooth Muscle Intracellular Ca
2؉
The smooth muscle or the endothelium of isolated, cannulated arteries were loaded with the Ca 2ϩ -sensitive fluorescent indicator fura 2 acetoxy-methyl, as described previously. 20 Changes in intracellular Ca 2ϩ {[Ca 2ϩ ] i } in the arterial endothelium and smooth muscle in response to increases in P i (from 0 to 80 mm Hg or to 160 mm Hg) were measured by the ratiometric fluorescence method using the Ionoptix Microfluorimeter System (Ionoptix Co). 20 Responses were also reassessed in the absence of extracellular Ca 2ϩ .
Detection of Pressure-Induced PKC␣ Phosphorylation by Western Blotting
Phosphorylation of PKC␣ was detected by Western blotting, as described previously. 23 Arteries were cannulated in a dual-vessel chamber (model CH/1/QT, Living System Instrumentation), pressurized to 80 mm Hg or 160 mm Hg (for 30 minutes at 37°C), and then snap-frozen in liquid nitrogen. Nonpressurized vessels served as controls. Protein samples were prepared 22, 23 in the presence of Na 3 VO 4 (1 mmol/L) and phosphatase inhibitors (Sigma). Equal amounts of protein (8 g) were electrophoresed on 10% SDS-PAGE gels, and Western blotting was performed using a phosphorylationspecific primary antibody for PKC␣ (Cell Signalling Technology, Beverly, Mass; 1:1000) and anti-rabbit IgG-horseradish peroxidase secondary antibody (Amersham Biosciences, Piscataway, NJ; 1:4000). Anti-␤-actin was used for normalization.
Immunofluorescent Labeling of Phospho-PKC␣
Isolated arteries pressurized to 160 mm Hg were treated with phosphatase inhibitors, embedded, snap-frozen in liquid nitrogen, and cryosectioned (thickness, 4 m). Immunofluorescent labeling 22 was performed with phospho-specific anti-PKC␣ primary antibody. DAPI was used for nuclear staining.
Immunoprecipitation and Detection of Pressure-Induced p47 phox Phosphorylation by Western Blotting
Isolated arteries were pressurized (for 30 minutes at 37°C) to 0, 80, or 160 mm Hg or 160 mm Hg plus 10 Ϫ6 mol/L chelerythrine or 0 mm Hg plus 10 Ϫ6 mol/L PMA, snap-frozen in liquid nitrogen, and lysed in a radio immunoprecipitation (RIPA) lysis buffer (Upstate USIA Inc) containing phosphatase inhibitors. Proteins were incubated with protein A beads (Amersham; 1 hour at 4°C) and with anti-p47 phox primary antibody (5 g, overnight at 4°C). Then, the samples were centrifuged (12 000g), the pellet was washed (3ϫ RIPA and 1ϫ 50 mmol/L Tris, pH 8.0), and the proteins were separated by SDS-PAGE, transferred to membranes, and probed with a primary antibody against phosphorylated serine residues (1:1000, 1 hour, Cell Signaling) and normalized for p47 phox content. 22, 23 
Materials
All chemicals, if otherwise not specified, were obtained from Sigma-Aldrich Co, and solutions were prepared on the day of the experiment. Final concentrations are reported in the text.
Data Analysis
Lucigenin chemiluminescence data and densitometric ratios were normalized to the respective control mean values. Selective portions of representative Western blots are shown for clarity. Data are expressed as the meanϮSEM. Statistical analyses of data were performed by Student's t test or by 2-way ANOVA followed by the Tukey post hoc test, as appropriate. PϽ0.05 was considered statistically significant.
Results
Flow-Induced Dilation
In control conditions, increases in intraluminal flow elicited significant dilations. These dilations were significantly reduced after the vessels were exposed to high P i ( Figure 1 ). Previous studies demonstrated that agonist-induced nitric oxide-mediated dilations are also impaired in vessels that were previously exposed to high P i in a similar manner. 17 Administration of SOD or apocynin (but not losartan or captopril) or removal of extracellular Ca 2ϩ prevented the high P i -induced impairment of flow-induced dilation (Figure 1 ).
Vascular O 2 ·؊ Production
Real-time lucigenin chemiluminescence measurements showed that an increase in P i from 0 mm Hg to 80 mm Hg resulted in minimal changes in vascular O 2 ·Ϫ production. In contrast, exposure to high P i (160 mm Hg) elicited biphasic increases in vascular O 2 ·Ϫ generation, with a rapid peak increase followed by a plateau phase (Figures 2A and 2B) . Incubation of the vessels with DPI or chelerythrine or removal of extracellular Ca 2ϩ prevented high P i -induced increases in O 2 ·Ϫ levels ( Figure 2C ). Scintillation counter measurements showed that levels of O 2 ·Ϫ remained significantly increased in vessels exposed to 160 mm Hg compared with arteries exposed to 80 mm Hg ( Figure 3A) . Pressurization of arteries to 120 mm Hg also resulted in moderate but significant increases (14Ϯ4%) in O 2 ·Ϫ generation. Increased O 2 ·Ϫ generation in high (160 mm Hg) P i -pretreated vessels was inhibited by cotreatment with SOD, DPI, chelerythrine, apocynin, staurosporin, or Tiron or by removal of extracellular Ca 2ϩ ( Figures 3A and 3B) , thus eliminating the difference between the groups. Increased O 2 ·Ϫ generation in high P i -treated ·Ϫ levels are present in both the smooth muscle (arrow) and the endothelium (arrowhead) of high pressure-exposed arteries (40ϫ; L, arterial lumen). E, Only weak EB staining is visible in normal pressure-exposed arteries. DAPI (blue) was used for nuclear staining.
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vessels was unaffected by losartan ( Figure 3B ). Incubation of control arteries with PMA (for 30 minutes) significantly increased O 2 ·Ϫ production, which could be inhibited by administration of chelerythrine, SOD, or DPI or by removal of extracellular Ca 2ϩ ( Figure 3C ). The Ca 2ϩ ionophore ionomycin also significantly increased vascular O 2 ·Ϫ generation, although its effect was smaller than that of PMA ( Figure 3C ).
Hydroethidine Fluorescence
In sections of arteries exposed to 160 mm Hg, ethidium bromide staining of nuclei was stronger than in sections of arteries exposed to 80 mm Hg (representative ethidium bromide fluorescent images are shown in Figures 2D and  2E) . Overlaying of ethidium bromide-stained fluorescent images (red) with images of the same vessel sections stained for smooth muscle ␣-actin (green) showed that high P i increased O 2 ·Ϫ levels in both the media and intima of arteries ( Figure 2D ).
Measurement of Endothelial and Smooth Muscle [Ca 2؉ ] i
Smooth muscle [Ca 2ϩ ] i was significantly greater at 160 mm Hg P i than at 80 mm Hg P i ( Figure 4B ), which corresponded to our previous findings, 20 whereas increases in P i had only a slight effect on [Ca 2ϩ ] i in the endothelium ( Figure 4A ). In the absence of extracellular Ca 2ϩ , both endothelial and smooth muscle [Ca 2ϩ ] i were substantially decreased and were unaffected by changes in P i ( Figures 4A and 4B ).
Pressure-Induced Phosphorylation of PKC␣
Increases in P i resulted in significantly increased phosphorylation of PKC␣ in arteries ( Figure 5A ). In arteries pressurized to 160 mm Hg, PKC␣ phosphorylation was significantly greater than in vessels exposed to 80 mm Hg ( Figure 5A ). Immunofluorescent labeling of sections of arteries pressurized to 160 mm Hg showed that phospho-PKC␣ was predominantly located in the media and the intima, whereas immunostaining of the adventitia was less evident ( Figure 5B ).
Pressure-Induced Phosphorylation of p47 phox
The phosphorylation of p47 phox in isolated arteries was analyzed by detecting phosphorylation of serine residues after p47 phox immunoprecipitation and SDS-PAGE. Pressurization of arteries resulted in significantly increased phosphorylation of p47 phox compared with nonpressurized vessels (Figure 5C ), as determined by densitometry analysis. In arteries pressurized to 160 mm Hg, p47
phox phosphorylation was substantially greater than in vessels exposed to 80 mm Hg. Chelerythrine prevented high P i -induced p47 phox phosphorylation, whereas PMA stimulation of nonpressurized vessels triggered the phosphorylation of p47 phox ( Figure 5C ).
Discussion
The new findings in the present study are that in high P iexposed isolated arteries, there is (1) 
Pressure-Induced Increase in Arterial O 2 ·؊ Generation
In isolated arteries, SOD-reversible endothelial dysfunction could be elicited in vitro in the absence of circulating factors by increasing P i to a hypertensive level (Figure 1 ), thus confirming our previous findings. 17 Other studies also showed that in the coronary and cerebral circulation, short-term increases in P i in vivo also impair endothelial function. [13] [14] [15] [16] Mechanosensitive production of reactive oxygen species has also been linked to pressure-induced constriction of arterioles. 24, 25 To provide further evidence for high P iinduced oxidative stress, we demonstrated with real-time lucigenin chemiluminescence measurements that high P i itself induced significant increases in arterial O 2 ·Ϫ generation (Figures 2A and 2B ), whereas normal levels of P i had minimal effect. High P i induced a rapid peak increase in O 2 ·Ϫ production that was followed by a plateau phase (Figure 2A) . Importantly, arterial O 2 ·Ϫ levels measured after exposure to high P i also remained elevated ( Figure  3A) . We have found a similar, sustained O 2 ·Ϫ generation recently in vascular ring preparations after short-term stretching, 21 thus suggesting that mechanical activation-induced O 2 ·Ϫ production is not readily reversible. High P i increased vascular O 2 ·Ϫ production in the endothelium and the smooth muscle, as shown by ethidium bromide staining ( Figure 2D ), thus suggesting that similar mechanosensitive pro-oxidant pathways are present in both cell types.
Role of NAD(P)H Oxidase
Because high P i -induced endothelial dysfunction ( Figure 1 ) and increased O 2 ·Ϫ generation ( Figures 2C and 3A) could be prevented by apocynin and DPI, it is likely that high P i itself activates NAD(P)H oxidases. The in vivo importance of high P i -induced activation of oxidases is supported by recent findings showing increased NAD(P)H oxidase-dependent vascular O 2 ·Ϫ production in virtually all forms of hypertension, 2, 5, 7, 8, 26 which can be reduced or prevented by lowering P i . 8, 11 Studies on cultured endothelial and smooth muscle cells 27 and on aortic rings 21 showing stretch-induced O 2 ·Ϫ generation also suggest that mechanosensitive pathways are coupled to NAD(P)H oxidase activity in both the arterial endothelium and smooth muscle. Previous studies suggested a role for locally produced angiotensin in vascular oxidative stress and modulation of flow-mediated responses. 28 Thus, we incubated the vessels with losartan and captopril to exclude the contribution of a local renin-angiotensin system, yet high P i still activated O 2 ·Ϫ generation ( Figure 3B ) and induced endothelial dysfunction (Figure 1) , providing further evidence for the direct role of high P i .
Role of Ca 2؉ and PKC-Dependent Signal Transduction
We found that removal of Ca 2ϩ and inhibition of PKC prevented high P i -induced O 2 ·Ϫ production ( Figures 3A and 3B) , indicating a role for mechanosensitive Ca 2ϩ signaling and PKC-dependent pathways in high P i -induced upregulation of NAD(P)H oxidase activity. This idea is consistent with the findings that high P i elicited significantly greater increases in smooth muscle [Ca 2ϩ ] i than normal levels of P i (Figure 4) . The important role of Ca 2ϩ signaling is also supported by the finding that administration of a Ca 2ϩ ionophore resulted in significantly increased arterial O 2 ·Ϫ production ( Figure 3C ). Further, pharmacological activation of PKC 2 elicited substantial increases in arterial NAD(P)H oxidasederived O 2 ·Ϫ generation ( Figure 3C ). Because removal of Ca 2ϩ during high-pressure treatment prevented endothelial dysfunc- 
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Pressure Activates NAD(P)H Oxidase Via PKCtion ( Figure 1 ) and increases in O 2 ·Ϫ production in high P iexposed arteries ( Figure 3A ) and phorbol ester-stimulated O 2 ·Ϫ generation in normotensive arteries could also be reduced by removal of Ca 2ϩ ( Figure 3C ), it is likely that Ca 2ϩ -dependent PKC isoforms are involved in the high P i -induced upregulation of arterial NAD(P)H oxidase activity. This idea is further supported by the findings that high P i elicited phosphorylation of PKC␣ 23 (Figure 5A ), the most abundant Ca 2ϩ -dependent PKC isoform in arteries. It seems that high P i induces phosphorylation and activation of PKC␣ in both the endothelium and smooth muscle, as indicated by immunostaining ( Figure 5B ) that leads to increased O 2 ·Ϫ production in both cell types ( Figure 2D ). The activity of NAD(P)H oxidases is thought to be regulated by phosphorylation of the cytosolic regulatory p47 phox subunit 29 that facilitates association of the membrane-bound and cytoplasmic subunits of the enzyme. 21 We found that high P i substantially increased phosphorylation of serine residues of p47 phox , an effect that could be prevented by inhibition of the serine/ threonine kinase PKC 2,3 ( Figure 5C ). Correspondingly, pharmacological activation of PKC resulted in phosphorylation of the p47 phox subunit ( Figure 5C ) and increased NAD(P)H oxidasedependent O 2 ·Ϫ production ( Figure 3C ). Thus, we conclude that hypertensive levels of P i itself are a sufficient stimulus for increased arterial O 2 ·Ϫ production, likely by inducing Ca 2ϩ -and PKC-dependent of phosphorylation and activation of the NAD(P)H oxidase ( Figure 5D ). This mechanism may contribute to the increased O 2 ·Ϫ levels and endothelial dysfunction in hypertension, regardless of its cause. In addition, high P i -induced NAD(P)H oxidase function in vivo is likely also stimulated by increased pulsatility 27, 30 and/or by increased levels of humoral factors, such as angiotensin II, 3, 29 that increase PKC activity via G protein-coupled receptors. One can speculate that chronic high P i -induced O 2 ·Ϫ generation by stimulating redox-sensitive gene expression also contributes to structural remodeling, because a reduction of systemic blood pressure could reverse morphological changes. 31 Finally, our findings also provide an explanation for the similar vasculoprotective effects of blood pressure lowering by pharmacological treatments with different mechanisms of action (eg, calcium antagonists, diuretics, and ACE inhibitors) in various forms of human hypertension.
